Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Johnston

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|February 22, 2002
Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivoPaul M Rogers, Philip J Beale, Mansour Al-Moundhri, et al.
Breast Cancer Research and Treatment|February 4, 2022
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experienceAlicia Okines, Tazia Irfan, Bernice Asare, et al.
Advances in Therapy|July 25, 2022
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple MyelomaJianming He, Heather Berringer, Bart Heeg, et al.
Journal of Thoracic Disease|April 16, 2026
Impact of non-tumor size related features on staging in non-small cell lung cancer: a population-level analysis of the SEER-medicare databaseRavi Rajaram, Barbara H Johnson, Qing Huang, et al.
The Breast Journal|August 24, 2017
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experienceAlicia Okines, Tazia Irfan, Komel Khabra, et al.
NPJ Breast Cancer|June 23, 2021
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroupsStephen Johnston, Joyce O'Shaughnessy, Miguel Martin, et al.
Nature Biotechnology|April 17, 2018
An in vivo model of functional and vascularized human brain organoidsAbed AlFatah Mansour, J Tiago Gonçalves, Cooper W Bloyd, et al.
Movement Ecology|March 16, 2024
Chinook salmon depth distributions on the continental shelf are shaped by interactions between location, season, and individual conditionCameron Freshwater, Sean C Anderson, David D Huff, et al.
Cancer Treatment and Research Communications|July 4, 2020
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experienceNicolò Matteo Luca Battisti, Frances Rogerson, Karla Lee, et al.
JAMA Oncology|June 10, 2016
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without LapatinibAleix Prat, Maggie C U Cheang, Patricia Galván, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|February 22, 2002
Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivoPaul M Rogers, Philip J Beale, Mansour Al-Moundhri, et al.
Breast Cancer Research and Treatment|February 4, 2022
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experienceAlicia Okines, Tazia Irfan, Bernice Asare, et al.
Advances in Therapy|July 25, 2022
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple MyelomaJianming He, Heather Berringer, Bart Heeg, et al.
Journal of Thoracic Disease|April 16, 2026
Impact of non-tumor size related features on staging in non-small cell lung cancer: a population-level analysis of the SEER-medicare databaseRavi Rajaram, Barbara H Johnson, Qing Huang, et al.
The Breast Journal|August 24, 2017
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experienceAlicia Okines, Tazia Irfan, Komel Khabra, et al.
NPJ Breast Cancer|June 23, 2021
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroupsStephen Johnston, Joyce O'Shaughnessy, Miguel Martin, et al.
Nature Biotechnology|April 17, 2018
An in vivo model of functional and vascularized human brain organoidsAbed AlFatah Mansour, J Tiago Gonçalves, Cooper W Bloyd, et al.
Movement Ecology|March 16, 2024
Chinook salmon depth distributions on the continental shelf are shaped by interactions between location, season, and individual conditionCameron Freshwater, Sean C Anderson, David D Huff, et al.
Cancer Treatment and Research Communications|July 4, 2020
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experienceNicolò Matteo Luca Battisti, Frances Rogerson, Karla Lee, et al.
JAMA Oncology|June 10, 2016
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without LapatinibAleix Prat, Maggie C U Cheang, Patricia Galván, et al.
Pageof 14